WEBINAR: The final furlong – your clinical trial data and top tips on regulatory submission
October 6 @ 10:00 am - 11:00 am
Join us for the next in the series of our Clinical Trial Special Interest Groups with Afortiori Development, at this webinar “The final furlong – Your clinical trial data and regulatory submission. Top tips on getting ready for regulatory submission”.
When a trial finishes, the ultimate goal is to have usable data that can be presented to regulators to make your case for your product’s approval. Join us to understand the key considerations you’ll need to be aware of when getting your data ready for regulatory scrutiny.
DURATION: 1 hour
This free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the SoLSTICE programme, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all.
Chaired by: Dr Nicola Wall, Chief Executive Officer, Afortiori Development Nicola co-founded Afortiori Development after a long career in clinical research within a variety of roles. Nicola has extensive experience and a proven track record in global clinical trial management, quality assurance and process management in the healthcare industry. Afortiori have built an impressive global team of clinical trial specialists, clinicians and biostatisticians with experience in adult, paediatric and neonatal clinical research, and both primary and secondary healthcare settings.
Greer Deal, Director, Global Regulatory Services
Greer has over 25 years’ experience in the life science sector and 15 years ago when her husband, Bobby Deal, identified a gap in the market, she co-founded Global Regulatory Services (GRS) and more recently, as part of the company’s expansion, they also established Med-Di-Dia in Ireland. Operating at the forefront of technology GRS is a specialist organisation with worldwide coverage providing solutions to the global life science industry focusing on regulatory affairs, quality compliance and innovation. With a worldwide network of professionals, GRS is able to support companies with emerging, novel technologies from foods to herbals, medical devices to IVDs, pharmaceuticals to regenerative therapies and borderline medicinal products. Greer is passionate about raising the profile of regulatory professionals and highlighting how regulatory affairs is a critical part of a product’s journey from concept to commercialisation and beyond.